The vasoactive peptide maxadilan from sand fly saliva inhibits TNF-α and induces IL-6 by mouse macrophages through interaction with the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor

Journal of Immunology

Volumn 160, Issue 4, 1998, Pages 1811-1816

  Soares, Milena B P ^a   Titus, Richard G ^b   Shoemaker, Charles B ^a   David, John R ^a   Bozza, Marcelo ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Immunology and Pathology   (United States)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYTOKINE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; INDOMETACIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MAXADILAN; PROSTAGLANDIN E2; RECEPTOR BLOCKING AGENT; RECOMBINANT PROTEIN; SALIVA PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE AGENT; VASODILATOR AGENT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEMALE; FLY; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RECEPTOR BINDING;

ADENYLATE CYCLASE; ANIMALS; CYCLIC AMP; DINOPROSTONE; FEMALE; INSECT PROTEINS; INTERLEUKIN-6; INTRACELLULAR FLUID; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; NEUROPEPTIDES; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PSYCHODIDAE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; RECEPTORS, PITUITARY HORMONE; SALIVARY PROTEINS; TUMOR NECROSIS FACTOR-ALPHA; VASODILATOR AGENTS;

EID: 0032519964     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Ribeiro, J. M. C. 1987. Role of saliva in blood-feeding by arthropods. Annu. Rev. Entomol. 32:463.
2. Titus, R. G., and J. M. Ribeiro. 1988. Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science 239:1306.
3. Titus, R. G., and J. M. C. Ribeiro. 1990. The role of vector saliva in transmission of arthropod-borne disease. Parasitol. Today 6:157.
4. Theodos, C. M., J. M. Ribeiro, and R. G. Titus. 1991. Analysis of enhancing effect of sand fly saliva on Leishmania infection in mice. Infect. Immun. 59:1592.
5. Liew, F. Y., S. Millot, C. Parkinson, R. M. J. Palmer, and M. S. 1990. Macrophage killing of Leishmania parasites in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144:4794.
6. Titus, R. G., C. M. Theodos, A. H. Shankar, and L. R. Hall. 1994. Interactions between Leishmania major and macrophages. Immunol. Ser. 60:437.
7. Theodos, C. M., and R. G. Titus. 1993. Salivary gland material from the sand fly Lutzomyia longipalpis has an inhibitory effect on macrophage function in vitro. Parasite Immunol. 15:481.
8. Hall, L. R., and R. G. Titus. 1995. Sand fly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production. J. Immunol. 155:3501.
9. Lerner, E. A., J. M. Ribeiro, R. J. Nelson, and M. R. Lerner. 1991. Isolation of maxadilan, a potent vasodilatory peptide from the salivary glands of the sand fly Lutzomyia longipalpis. J. Biol. Chem. 266:11234.
10. Lerner, E. A., and C. B. Shoemaker. 1992. Maxadilan: cloning and functional expression of the gene encoding this potent vasodilator peptide. J. Biol. Chem. 267:1062.
11. Grevelink, S. A., J. Osborne, J. Loscalzo, and E. A. Lerner. 1995. Vasorelaxant and second messenger effects of maxadilan. J. Pharmacol. Exp. Ther. 272:33.
12. Moro, O., T. J. Tsomides, M. Tajima, and E. A. Lerner. 1995. Maxadilan binds to membrane fractions of brain tissues. Biochem. Biophys. Res. Commun. 216: 234.
13. Qureshi, A. A., A. Asahina, M. Ohnuma, M. Tajima, R. D. Granstein, and E. A. Lerner. 1996. Immunomodulatory properties of Maxadilan, the vasodilator peptide from sand fly salivary gland extracts. Am. J. Trop. Med. Hyg. 54:665.
14. Moro, O., and E. A. Lerner. 1996. Maxadilan, the vasodilator peptide from sand flies, is a specific pituitary adenylate cyclase activating peptide type I receptor agonist. J. Biol. Chem. 272:966.
15. Arimura, A. 1992. Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Regul. Pept. 37:287.
16. Christophe, J. 1993. Type I receptor for PACAP (a neuropeptide even more important than VIP?). Biochim. Biophys. Acta 1154:183.
17. Tatsuno, I., A. Somogyvári-Vigh, K. Mizuno, P. E. Gottschall, H. Hidaka, and A. Arimura. 1991. Neuropeptide regulation of interleukin-6 production from the pituitary: stimulation by pituitary adenylate cyclase activating polypeptide and calcitonin gene-related peptide. Endocrinology 129:1797.
18. Gottschall, P. E., I. Tatsuno, and A. Arimura. 1994. Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interteukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP). Brain Res. 637:197.
19. Desai, B. J., and J. M. Burrin. 1994. PACAP-38 positively regulates glycoprotein hormone a-gene expression in placental cells. Mol. Cell. Endocrinol. 99:31.
20. Tatsuno, I., P. E. Gottschall, and A. Arimura. 1991. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide. Endocrinology 128:728.
21. Martinez, C., M. Delgado, R. P. Gomariz, and D. Ganea. 1996. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes. J. Immunol. 156:4128.
22. Zhong, C., P. J. Skelly, D. Leaffer, R. L. Cohn, J. P. Caulfield, and C. B. Shoemaker. 1995. Immunolocalization of a Schistosoma mansoni facilitated glucose transporter to the basal, but not the apical membranes of the surface syncytium. Parasitotogy 110:383.
23. Chakkalath, H. R., and R. G. Titus. 1994. Leishmania major-parasitized macrophages augment Th2-type T cell activation. J. Immunol. 153:4378.
24. Freudenberg, M. A., D. Keppler, and C. Galanos. 1986. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect. Immun. 51:891.
25. Kunkel, S. L., R. C. Wiggins, S. W. Chensue, and J. Larrick. 1986. Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem. Biophys. Res. Comm. 137:404.
26. Fiorentino, D. F., A. Zlotnik, T. R. Mossman, M. Howard, and A. O'Garra. 1991. Interleukin-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815.
27. Bogdan, C., Y. Vodovotz, and C. F. Nathan. 1991. Macrophage deactivation by interleukin 10. J. Exp. Med. 174:1549.
28. de Waal Malefyt, R., J. Abrams, B. Bennett, C. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
29. Aderka, D., J. Le, and J. Vilcek. 1989. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in culture human monocytes, U937 cells, and in mice. J. Immunol. 143:3517.
30. Miyata, A., A. Arimura, R. R. Dahl, N. Minamino, A. Uehara, L. Jiang, M. D. Culler, and D. H. Coy. 1989. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164:567.
31. Miyata, A., L. Jiang, R. D. Dahl, C. Kitada, K. Kubo, M. Fujino, N. Minamino, and A. Arimura. 1990. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP 38). Biochem. Biophys. Res. Commun. 170:643.
32. Cauvin, A., P. Robberecht, P. De Neef, P. Gourlet, A. Vandermeers, M. C. Vandermeers-Piret, and J. Christophe. 1991. Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord. Regul. Pept. 35:161.
33. Strassmann, G., V. Patil-Koota, F. Finkelman, M. Fong, and T. Kambayashi. 1994. Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180: 2365.
34. Ribeiro, J. M. C., A. Vechereau, G. B. Modi, and R. B. Tesh. 1989. A novel vasodilatory peptide from the salivary glands of the sand fly Lutzomyia longipalpis. Science 243:212.
35. Sehgal, P. B., Z. Walther, and I. Tamm. 1987. Rapid enhancement of beta 2-interferon/B-cell differentiation factor BSF-2 gene expression in human fibroblasts by diacylglycerols and the calcium ionophore A23187. Proc. Natl. Acad. Sci. USA 84:3663.
36. Zhang, Y., J. X. Lin, and J. Vilcek. 1988. Synthesis of interleukin 6 (interferon-beta 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J. Biol. Chem. 263:6177.
37. Ray, A., S. B. Tatter, L. T. May, and P. B. Sehgal. 1988. Activation of the human "beta 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists. Proc. Natl. Acad. Sci. USA 85:6701.
38. Dendorfer, U., P. Oettgen, and T. A. Libermann. 1994. Multiple regulatory elements in the interleukin-6 gene mediated induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol. Cell. Biol. 14:4443.
39. Deutsch, P. J., and Y. Sun. 1992. The 38-amino acid form of pituitary adenylate cyclase-activating peptides stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. J. Biol. Chem. 267:5108.
40. Spengler, D., C. Waeber, C. Pantaloni, F. Holsboer, J. Bockaert, P. H. Seeburg, and L. Journot. 1993. Differential signal transduction by five splice variants of the PACAP receptor. Nature 365:170.
41. + channel currents in vascular smooth muscle cells: involvement of PKC and PKA. FASEB J. 10:1310.
42. Bailly, S., B. Ferrua, M. Fay, and P. M. Gougeror. 1990. Differential regulation of IL-6, IL-1α, IL-1β and TNFα production in LPS-stimulated human monocytes: role of cyclic AMP. Cytokine 2:205.
43. Tannenbaum, C. S., and T. A. Hamilton. 1989. Lipopolysaccharide induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP. J. Immunol. 142:1274.
44. Lotz, M., J. H. Vaughan, and D. A. Carson. 1988. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241:1218.
45. Martin, F. C., P. A. Anton, J. A. Gornbein, F. Shanahan, and J. E. Merrill. 1993. Production of interleukin-1 by microglia in response to substance P: role for a nonclassical NK-1 receptor. J. Neuroimmunol. 42:53.
46. Luber-Narod, J., R. Kage, and S. E. Leeman. 1994. Substance P enhances the secretion of tumor necrosis factor-α from neuroglial cells stimulated with lipopolysaccharide. J. Immunol. 152:819.
47. Champagne, D. E., and J. M. C. Ribeiro. 1994. Sialokinin I and II: vasodilatory tachykininis from the yellow fever mosquito Aedes aegypti. Proc. Natl. Acad. Sci. USA 91:138.
48. Cross M. L., E. W. Cupp, and F. J. Enriquez. 1994. Modulation of murine cellular immune responses and cytokines by salivary gland extract of the black fly Simulium vittatum. Trop. Med. Parasitol. 45:119.
49. Cross M. L., E. W. Cupp, and F. J. Enriquez. 1994. Differential modulation of murine cellular immune responses by salivary gland extract of Aedes aegypti. Am. J. Trop. Med. Hyg. 51:690.
50. 2-dependent mechanism. J. Exp. Med. 180:1077.
51. Ramachandra R. N., and S. K. Wikel. 1992. Modulation of host-immune responses by ticks (Acari: Ixodidae): effect of salivary gland extracts on host macrophages and lymphocyte cytokine production. J. Med. Entomol. 29:818.
52. Jones L. D., E. Hodgson, and P. A. Nuttall. 1989. Enhancement of virus transmission by tick salivary glands. J. Gen. Virol. 70:1895.